Journal
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
Volume 28, Issue 2, Pages 198-201Publisher
UNIV CHICAGO PRESS
DOI: 10.1086/511789
Keywords
-
Ask authors/readers for more resources
An outbreak of Clostridium difficile-associated disease ( CDAD) caused by the epidemic North American pulsed-field gel electrophoresis type 1 ( NAP1) strain began after a formulary change from levofloxacin to moxifloxacin. Cases of CDAD were associated with moxifloxacin use, but a formulary change back to levofloxacin failed to reduce rates of disease. Substituting use of one fluoroquinolone with use of another without also controlling the overall use of drugs from this class is unlikely to control outbreaks caused by the NAP1 strain of C. difficile.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available